Vincent J. Angotti
2023
In 2023, Vincent J. Angotti earned a total compensation of $1.2M as Chief Executive Officer at AcelRx Pharmaceuticals, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $346,176 |
|---|---|
| Option Awards | $162,662 |
| Salary | $655,636 |
| Stock Awards | $34,320 |
| Other | $13,200 |
| Total | $1,211,994 |
Angotti received $655.6K in salary, accounting for 54% of the total pay in 2023.
Angotti also received $346.2K in non-equity incentive plan, $162.7K in option awards, $34.3K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Vincent J. Angotti's compensation ranked 999th out of 2,937 executives tracked by ExecPay. In other words, Angotti earned more than 66.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 999 out of 2,937 | 66th |
Division Manufacturing | 599 out of 1,622 | 63rd |
Major group Chemicals And Allied Products | 411 out of 904 | 55th |
Industry group Drugs | 400 out of 867 | 54th |
Industry Pharmaceutical Preparations | 273 out of 625 | 56th |
Source: SEC filing on April 29, 2024.
Angotti's colleagues
We found two more compensation records of executives who worked with Vincent J. Angotti at AcelRx Pharmaceuticals in 2023.
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019